JusticeItaly Official institution
Italy approves three new Zestan tablet packs from S.F. Group
Italy's medicines agency AIFA has approved new packs of Zestan, a cholesterol-lowering tablet combining ezetimibe and simvastatin, in decision AAM/PPA 594/2026 dated 23 October 2026. The license holder is S.F. Group S.r.l. of Rome. The three new packs each hold 60 tablets in three strengths, and the medicine needs a prescription.
This summary was generated by AI; the official source prevails.
What does it mean?
Zestan, a cholesterol medicine, can now be bought in three new 60-tablet packs in Italy. A doctor's prescription is still required to get it.
Who is affected?
Patients in Italy who take Zestan and the pharmacies that supply it